webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate

  CAS No.: 1006592-59-1   Cat No.: BADC-00428   Purity: ≥98% 4.5  

2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate is a small molecule compound. It has attracted great attention in the biomedical field because of its remarkable ability to fight bacterial infections. Its unparalleled efficacy in precisely targeting drug delivery systems and amplifying therapeutic effects has been extensively documented through comprehensive research.

2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate

Structure of 1006592-59-1

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C22H34N2O7
Molecular Weight
438.52
Shipping
Room temperature

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(undec-10-ynoylamino)ethoxy]ethoxy]propanoate;
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(undec-10-ynoylamino)ethoxy]ethoxy]propanoate
Canonical SMILES
C#CCCCCCCCCC(=O)NCCOCCOCCC(=O)ON1C(=O)CCC1=O
InChI
InChI=1S/C22H34N2O7/c1-2-3-4-5-6-7-8-9-10-19(25)23-14-16-30-18-17-29-15-13-22(28)31-24-20(26)11-12-21(24)27/h1H,3-18H2,(H,23,25)
InChIKey
OMCLMLMPUVUIQP-UHFFFAOYSA-N
Appearance
Soild powder
Shipping
Room temperature

One of the key applications of 2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate is its use in medicinal chemistry. This compound serves as a versatile building block for the synthesis of various biologically active molecules. Due to its structural complexity and unique functional groups, it can be employed in the development of novel drugs targeting a range of diseases, including cancer, cardiovascular disorders, and infectious diseases. Moreover, its ability to act as a linker in drug conjugation strategies enhances the efficacy and specificity of therapeutic agents, paving the way for advanced treatment options.

In the field of organic synthesis, 2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate is utilized as a coupling reagent. Its reactivity allows for the formation of amide bonds and ester linkages, which are crucial in the synthesis of peptides, oligonucleotides, and other complex organic molecules. This makes it an essential component in the chemical toolbox of researchers aiming to construct sophisticated molecular architectures with high precision and efficiency. Furthermore, its stability and compatibility with a wide range of substrates make it a preferred choice in organic synthesis protocols.

Another significant application of this compound is in materials science, particularly in the development of advanced polymers and coatings. The presence of reactive functional groups enables it to participate in polymerization reactions, resulting in materials with enhanced mechanical properties, thermal stability, and chemical resistance. These advanced materials find applications in various industries, including aerospace, automotive, and electronics, where high-performance materials are essential. Additionally, its incorporation into coatings can impart unique surface properties, such as hydrophobicity or antimicrobial activity, thereby extending the functionality and lifespan of the coated products.

In the realm of biomedical research, 2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate is employed in the design of bio-conjugates and biocompatible materials. Its ability to form stable covalent bonds with biomolecules like proteins, antibodies, and DNA makes it valuable for creating targeted drug delivery systems, diagnostics, and tissue engineering scaffolds. By enabling the precise attachment of therapeutic or imaging agents to biological targets, this compound enhances the specificity and effectiveness of biomedical interventions, contributing to the advancement of personalized medicine and bioengineering technologies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Mc-MMAD | 2,5-dioxopyrrolidin-1-yl 18-((4-(3,5-dioxohexyl)phenyl)amino)-14,18-dioxo-4,7,10-trioxa-13-azaoctadecan-1-oate | Acid-PEG3-SS-PEG3-acid | IgG1-VcMMAE | 4-Formyl-N-(2-(2-Methoxy-4-Methylphenoxy)ethyl)benzamide | Seco-Duocarmycin MA | CHO-Ph-CONH-PEG3-NHS ester | Methyltetrazine-PEG4-oxyamine | sulfo-LC-SPDP | N-Boc-N-bis(PEG4-OH) | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate
Send Inquiry
Verification code
Inquiry Basket